Design purposes
Cyprotex Logo - Click to go to home page
Design purposes
Design purposes
Image title - News
23 May 2003

Appointment of Adviser

The Board of Cyprotex PLC is delighted to announce the appointment of Durlacher Limited as Nominated Adviser and Broker to the Company.

For further information:

Dr David Leahy, Joint Chief Executive Officer, Chief Scientific Officer
John Nicholson, Joint Chief Executive Officer, Chief Operating Officer
Cyprotex PLC
Tel: +44 (0) 1625 505 100
j.nicholson@cyprotex.com
d.leahy@cyprotex.com
www.cyprotex.com

Grant Harrison
Durlacher
Tel: +44(0) 20 7459 3600

Media enquiries:

Henry Harrison-Topham/ Heather Salmond
Bankside Consultants Limited
Tel: +44 (0) 20 7444 4140
henry.ht@bankside.com
www.bankside.com



News Contact:

Robert Morrisson Atwater, Chairman & CEO
+44 1625 505 152
ir@cyprotex.com
Image - design element Design purposes
Request an information pack:

  Design purposesLegal Disclaimer